First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

528 Reviews

Credit Rating - PM PHARMA PROJECT CONSULTING LIMITED

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: PM PHARMA PROJECT CONSULTING LIMITED, 1 WORSLEY COURT HIGH STREET, WORSLEY, MANCHESTER, M28 3NJ. The legal status is a Private Limited Company and the current status at the registry of companies is Active - Proposal to Strike off. The last filed accounts are dated 30 April 2017. The company was incorporated on 23 April 2013.

The accounts next due date is 31 January 2019. There are no mortgages.

The above was based on public record information as at 17 February 2025 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 08500451
Date Incorporated: 23 April 2013
Date Latest Accounts: 30 April 2017
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 08500451
Annual Return: 23 April 2016
Registered Office: 1 WORSLEY COURT HIGH STREET, WORSLEY, MANCHESTER, M28 3NJ
SIC Code and Operations: 82990
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

PM PHARMA PROJECT CONSULTING LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 27 February 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
12799463 PM PHOENIX LTD Active - Proposal to Strike off
07933029 PM PHOTOGRAPHY LIMITED Active
11526314 PM PHYSIO LIMITED Active
10548512 PM PHYSIOTHERAPY & SPORTS INJURY LTD Active
14920140 PM PICTURES LIMITED Active - Proposal to Strike off

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd